Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Aguora Hills, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncotelic Therapeutics, Inc. has filed 1,215 SEC EDGAR filings since 04 Apr 1996

SEC filing history

Showing 276-300 of 781 matching filings.

Per page
25
Current page
12
8-K File 000-21990

8-K filing

Filing date
12 Jun 2019
Reporting date
10 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K filing

Filing date
05 Jun 2019
Reporting date
30 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K filing

Filing date
04 Jun 2019
Reporting date
04 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14C File 000-21990

PRE 14C

Filing date
22 May 2019
Reporting date
14 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-339030

D filing

Filing date
07 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-339029

D filing

Filing date
07 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-45691

SC 13D

Filing date
03 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
02 May 2019
Reporting date
22 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
02 May 2019
Reporting date
22 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
02 May 2019
Reporting date
22 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
02 May 2019
Reporting date
22 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
02 May 2019
Reporting date
22 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-45691

SCHEDULE 13D

Filing date
02 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-45691

SCHEDULE 13D

Filing date
02 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-45691

SCHEDULE 13D

Filing date
02 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-45691

SCHEDULE 13D

Filing date
02 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
30 Apr 2019
Reporting date
30 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
25 Apr 2019
Reporting date
22 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
18 Apr 2019
Reporting date
17 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
16 Apr 2019
Reporting date
10 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 000-21990

NT 10-K

Filing date
02 Apr 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45691

SABBY 13G MATN 1.02.19

Filing date
02 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .